Role of sirolimus topical application in recalcitrant cases of vernal keratoconjuctivitis
DOI:
https://doi.org/10.7439/ijbr.v8i5.4140Keywords:
Intramedullary nailing, Long bone diaphyseal fractures, Reaming, Internal fixatorAbstract
Aim: To study the role of sirolimus topical application (0.03% and 0>1% concentration) in recalcitrant cases of vernal keratoconjuctivitis in the region of Bikaner, Rajasthan. Materials and Methods: After patient selection of suspected vernal keratoconjuctivitis sociodemographic data risk factors and clinical symptoms were recorded. Ophthalmic examination was performed including records details of symptoms, drugs used, visual acuity, intraocular pressure measurement slit lamp examination. Patients categorized according symptoms and prepared sirolimus eye drop prescribed to patient in two groups and follow up done in every 15 day for 3 month Results: Male preponderance was seen in the ratio 3.17:1. 68% cases were students followed by 20% cases involved in outdoor activity. All the cases were bilateral and most of seen in the summer month of April-June i.e. 42%. 100% improvement in itching, redness, watering, ropy discharge, photophobia and in corneal involvement than conjunctival hyperemia, papillary hypertrophy, gelatinous ring around limbus and cobblestone lesion have less improvement. 0.1% sirolimus e/d have faster action than 0.03% Conclusion: Sirolimus eye drop is effective and sare therapy for recalcitrant cases of vernal keratoconjunctivitis. Both concentrations of sirolimus are effective and safe but 0.1% has faster action than 0.03%. Higher concentration (0.1%) used in severe cases for 30 days followed by lower concentration (0.03%). Sirolimus eye drop is alternate of steroid drop for long term use.Downloads
References
Angelucci. Arch. Ottal., 5,270(1898).(Quoted by Duke Elder,1965)
Saemisch. Graefe- Saemisch Hb. D. ges. Augenheilk., 1st edition, Leipzing, 4, 28(1876). (Quoted by Duke Elder, 1965).
Togby. Folia Ophthal. Orient. 1,168(1933). Rep. Giza Mem. ophthal. Lab. 8, 103(1933). (Quoted by Duke Elder,1965)
Biegelman. Amer. J Ophthal., 15, 95(1932); 17, 149(1934). Vernal conjunctivitis, Los Angeles(1950). (Quated by Duke Elder,1965)
Lyons. Rep. Giza Mem. Ophthal. Lab.1936; 11: 121; 12, app. 2(1937). (Queted by Duke Elder, 1965)
Neumann, Gutmann, Blumenkrantz and Michaelson. Amer. J Ophthal.1959; 47: 166.
Papamatheakis. Vernal conjunctivitis- Its etiology and treatment. Athen Med Machr 16(3): 161 (cited from Excerpta Medica 12:16(11): 505, Abstract no.2241(1962)
Vichanond P, Tantimongkolsuk C, Dumrongkigchaiporn P, Jirapongsananusuk, Visitsunthorn N, Kosrirukvongs P. J Allergy Clin. Immunology 2004: 113(2): 355-8.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.